Stockscreener 앱 받기
2.70
2.88%
-0.08
시간 외 거래:
2.72
0.02
+0.74%
전일 마감가:
$2.78
열려 있는:
$2.79
하루 거래량:
568.41K
Relative Volume:
0.69
시가총액:
$373.36M
수익:
-
순이익/손실:
$-45.44M
주가수익비율:
-7.7143
EPS:
-0.35
순현금흐름:
$-42.28M
1주 성능:
-8.47%
1개월 성능:
+1.89%
6개월 성능:
-22.86%
1년 성능:
+167.33%
1일 변동 폭
$2.67
$2.805
1주일 범위
$2.67
$3.03
52주 변동 폭
$1.07
$4.08
Compass Therapeutics Inc Stock (CMPX) Company Profile
명칭
Compass Therapeutics Inc
전화
617-500-8099
주소
80 GUEST STREET, BOSTON
CMPX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
2.70 | 402.40M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-01 | 재개 | Raymond James | Outperform |
| 2025-04-02 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-24 | 개시 | Guggenheim | Buy |
| 2025-02-19 | 개시 | Piper Sandler | Overweight |
| 2024-12-23 | 개시 | D. Boral Capital | Buy |
| 2024-11-15 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-16 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2023-01-31 | 개시 | Jefferies | Buy |
| 2023-01-27 | 개시 | Stifel | Buy |
| 2022-05-23 | 재개 | H.C. Wainwright | Buy |
| 2022-03-15 | 개시 | Ladenburg Thalmann | Buy |
| 2022-01-19 | 개시 | B. Riley Securities | Buy |
| 2021-12-22 | 개시 | Raymond James | Outperform |
| 2021-12-20 | 개시 | SVB Leerink | Outperform |
| 2021-12-15 | 개시 | Wedbush | Outperform |
모두보기
Compass Therapeutics Inc 주식(CMPX)의 최신 뉴스
Will Compass Therapeutics Inc. bounce back from current supportFree Trade Setups With AI Powered Filters - Newser
Published on: 2025-08-11 00:52:59 - beatles.ru
Has Compass Therapeutics Inc. formed a bullish divergenceFree Breakout Confirmation With Entry Tracker - Newser
Using Ichimoku Cloud for Compass Therapeutics Inc. technicalsFree Price Action Based Buy Opportunity List - Newser
Visualizing Compass Therapeutics Inc. stock with heatmapsDaily Profit Watch With Forecast Confidence - Newser
How Compass Therapeutics Inc. stock performs during market volatilityEntry and Exit Strategy for Swing Traders - Newser
Using data filters to optimize entry into Compass Therapeutics Inc.Free Short Term Trading Opportunity Watch - Newser
What recovery options are there for Compass Therapeutics Inc.Short-Term Trade Setup with Forecast Insight - Newser
Will Compass Therapeutics Inc. continue its uptrendFree Entry Plan for Oversold Reversal Stocks - Newser
What makes Compass Therapeutics Inc. stock price move sharplyFree Short Term Buy Zone Stock Alerts - Newser
Compass Therapeutics Inc. stock retracement – recovery analysisFree Swing Setup With Technical Confirmation - Newser
Momentum divergence signals in Compass Therapeutics Inc. chartBuy Strategy Tracker with Growth Indicators - Newser
Detecting support and resistance levels for Compass Therapeutics Inc.Entry Confirmation Using Short-Term Forecasting - Newser
Compass Therapeutics (CMPX) Expected to Announce Earnings on Monday - Defense World
Is Compass Therapeutics Inc. showing signs of accumulationDaily Market Movers Screener with Filters - Newser
What analysts say about Compass Therapeutics Inc. stock outlookWeekly Outlook for Short Term Investors - Newser
Compass Therapeutics CMPX 2025Q2 Earnings Preview Downside Ahead on Unclear Revenue Prospects - AInvest
Using data tools to time your Compass Therapeutics Inc. exitFree Buy Alerts With Low Risk Confirmation - Newser
Compass Therapeutics Inc. stock prediction for this weekTrend Analysis for Safer Market Entries - Newser
Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025 - The Manila Times
Is a relief rally coming for Compass Therapeutics Inc. holdersPrice Movement and Market Sentiment Analysis - Newser
What to expect from Compass Therapeutics Inc. in the next 30 daysValue Holding Return Summary With Outlook - Newser
How to integrate Compass Therapeutics Inc. into portfolio analysis toolsFree Growth Based Stock Signal Screener - Newser
Earnings visualization tools for Compass Therapeutics Inc.Portfolio Positioning Strategy With Timing - Newser
Is Compass Therapeutics Inc. forming a reversal patternIntraday Strategy with Real Time Monitoring - Newser
Heatmap analysis for Compass Therapeutics Inc. and competitorsFree Sector Based Breakout Stock Forecast - Newser
Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Average Rating of “Buy” from Analysts - Defense World
What does recent volatility data suggest for Compass Therapeutics Inc.Machine Learning Intraday Signal Forecast - Newser
Does Compass Therapeutics Inc. stock perform well during market downturnsDynamic growth stocks - Jammu Links News
How volatile is Compass Therapeutics Inc. stock compared to the marketInvest confidently with real-time updates - Jammu Links News
What are the latest earnings results for Compass Therapeutics Inc.Free Expert Stock Watchlist - Jammu Links News
What is the dividend policy of Compass Therapeutics Inc. stockUnlock powerful market trend analysis - Jammu Links News
What are analysts’ price targets for Compass Therapeutics Inc. in the next 12 monthsNavigate market shifts with confidence - Jammu Links News
What drives Compass Therapeutics Inc. stock priceAccelerated investment success - Jammu Links News
What institutional investors are buying Compass Therapeutics Inc. stockCapitalize on momentum-driven stocks - Jammu Links News
Is it the right time to buy Compass Therapeutics Inc. stockFree Stock Selection - Jammu Links News
Why is Compass Therapeutics Inc. stock attracting strong analyst attentionDynamic profit expansion - Jammu Links News
What are Compass Therapeutics Inc. company’s key revenue driversMarket-leading capital gains - Jammu Links News
When is the best time to exit Compass Therapeutics Inc.Short Term Opportunity Finder with Tools - Newser
Price action breakdown for Compass Therapeutics Inc.Weekly Return Plan for Conservative Traders - Newser
Compass Therapeutics Inc (CMPX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):